Neoclone Biotechnologies International is categorized under Medical Research in Madison, WI and active since 1999.
Neoclone Biotechnologies International was established in 1999, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 3254140 by the NAICS.
If you are seeking more information, feel free to contact Mark Jackson, Owner at the company’s single location by writing to 1202 Ann St, Madison, Wisconsin WI 53713 or by phoning (608) 260-8190. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Neoclone Biotechnologies International |
| Contact Person: | Mark Jackson, Owner |
| Address: | 1202 Ann St, Madison, Wisconsin 53713 |
| Phone Number: | (608) 260-8190 |
| Website Address: | neoclone.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 3254140 |
| Share This Business: |
Neoclone Biotechnologies International was started in 1999 to provide professional Medical Research under the SIC code 8733 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Mark Jackson, Owner for inquiries that concern Neoclone Biotechnologies International by calling the company number (608) 260-8190, as your correspondence is most welcome. Additionally, the physical location of the single location of Neoclone Biotechnologies International can be found at the coordinates 43.036587,-89.405029 as well as the street address 1202 Ann St in Madison, Wisconsin 53713.
For its online presence, you may visit Neoclone Biotechnologies International’s website at neoclone.com and engage with its social media outlets through on Twitter and on Facebook.